A routine stop with life-altering fallout
On a winter afternoon in Clermont-Ferrand, Lino, 43, parked his camper van outside his doctor’s office and stepped into a legal grey area he never saw coming. Minutes after cutting the engine, a police officer approached and administered a roadside saliva test, routine near a known drug-dealing hotspot. The result flashed positive, even though Lino insists he is not a drug user. His only “offense,” he says, is following a prescription for therapeutic morphine to manage pain from a serious illness. What the test cannot do, however, is distinguish between medically prescribed morphine and illicit heroin—both opiate derivatives that trigger the same screening response. For a law that treats all opiates as stupéfiants, the nuance of medical context evaporates on the spot.
When the law meets medicine
The first roadside result cost him his license, and the experience left him stunned and angry. According to specialized road-law attorneys, the immediate saliva screens can react to a wide range of molecules, including fully legal medications. The only definitive way to contest is a blood test, which Lino says he was not clearly informed he could request. Even blood analysis, medical experts note, detects morphine but cannot pinpoint its origin—pharmacy counter or street corner. In France, morphine is legally classified as a narcotic, and the Code does not distinguish between a prescribed drug and an illicit substance when it comes to driving. The consequences flow from the classification alone, not from proven impairment behind the wheel.
“C’est une difficulté à laquelle nous sommes confrontés depuis longtemps,” said road-law specialist Sarah Juillard, highlighting a tension between public safety and the realities of modern medicine.
A problem wider than one driver
This single case exposes a fault line affecting many drivers who rely on legitimate treatments. Prescribed morphine is used by hundreds of thousands across France, and codeine by several million, according to medical specialists. Several cough and pain medications can tip a saliva test positive, regardless of patient compliance. For routine road checks, the law’s black-and-white approach clashes with a clinical world painted in gradients. The risk is not only legal but deeply personal, especially when health, work, and family duties collide with a binary strip test. A protective framework for road safety must still account for therapeutic reality.
- Morphine-based analgesics prescribed for severe pain, including oral and transdermal forms.
- Codeine-containing syrups and tablets, common for coughs and moderate pain.
- Ethylmorphine and pholcodine cough preparations, historically available in pharmacies.
- Other opiate derivatives that may confuse screening devices despite legitimate use.
The second stop and spiraling consequences
Two months later, still awaiting administrative confirmation of any suspension, Lino drove to another medical appointment and parked outside the same practice. The same officer approached, performed the same test, and obtained the same result: positive, followed by another forfeiture of his license. The impact has been punishing for his already fragile routine. He says he can no longer drive to Saint-Étienne for cancer treatment, attend critical consultations, or manage the logistics of shared custody for his young son. What began as a routine check has become a chasm separating him from care, income, and basic mobility. Between procedural consistency and individual fairness, he feels stranded in a space where both sides lose.
What justice looks like now
The case will now be argued in court, where judges must weigh the classification of narcotics against the indispensability of care. Experts stress that current rules prohibit driving with narcotics—legal or illegal—without evaluating actual impairment. That framework, they argue, can create perverse outcomes for compliant patients whose test results say everything about chemistry and little about safety behind the wheel. As medical and legal voices call for better protocols and clearer guidance, one driver’s predicament crystallizes a national dilemma. A balance must be struck between public protection and the right to dignified, uninterrupted treatment.
“It’s an injustice,” Lino says, summing up the human cost behind an administrative decision that treats his lifeline for pain as a criminal signal. Until the law catches up with medical reality, many ordinary patients may continue to face extraordinary consequences for taking exactly what their doctors prescribe.
